trifluoperazine has been researched along with Cardiotoxicity in 1 studies
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Goda, AE | 1 |
Elenany, AM | 1 |
Elsisi, AE | 1 |
1 other study available for trifluoperazine and Cardiotoxicity
Article | Year |
---|---|
Novel in vivo potential of trifluoperazine to ameliorate doxorubicin-induced cardiotoxicity involves suppression of NF-κB and apoptosis.
Topics: Animals; Apoptosis; Cardiotoxicity; Cardiotoxins; Caspase 3; Doxorubicin; Male; Mice; Myocardium; Tr | 2021 |